Presidio Medical has received an IDE approval from the FDA, enabling a pivotal study of its neuromodulation platform.

Epiminder has reported the outcomes from the landmark UMPIRE (sUb-scalp Monitoring ePileptic selzuREs) trial evaluating ...

Spanish company Aortyx has secured €13.8m ($15.8m) in a Series A financing round to further develop its bioresorbable patch, ...

The health secretary addressed NHS employees a day after the £29bn NHS funding was announced. A £29bn investment into the ...

GE HealthCare has released software combining its own imaging functionalities with tools enabled by a platform developed by ...